C–H Methylation Strategies in Medicinal Chemistry

The installation of methyl groups directly onto unactivated C–H bonds has emerged as a transformative approach in drug discovery, enabling subtle modulation of physicochemical and pharmacokinetic properties. By converting inert C–H bonds into C–Me units, medicinal chemists can exploit the so-called “magic methyl” effect to enhance potency, selectivity and metabolic stability of lead compounds. Strategies encompass both directed and undirected approaches, utilising transition-metal catalysis (iridium, nickel, copper), photochemical activation and mechanochemical protocols. Directed methods employ coordinating functional groups to guide site-selective methylation of sp2 or sp3 centres, while undirected late-stage functionalisation permits the modification of complex scaffolds without preinstalled handles. Recent advances have also emphasised sustainability, leveraging solvent-free grinding, green oxidants and mild reaction conditions. Together, these techniques provide a versatile toolkit for rapid analogue generation and fine-tuning of drug-like molecules on a preparative scale.

Research from Nature Portfolio

Recent studies have described a photochemically activated peroxide/nickel(II) system that achieves undirected C(sp3)–H methylation of unactivated tertiary centres with high selectivity and broad functional-group compatibility. This protocol allows late-stage methylation of complex natural products, peptides and active pharmaceutical ingredients under mild conditions, thereby facilitating exploration of methylation effects on biological activity. Earlier foundational research introduced a copper-catalysed methylative difunctionalisation of alkenes, converting unactivated olefins into methylated heterocycles through radical pathways. Using simple peroxide sources, this approach generates quaternary centres in tetrahydrofurans, lactones and pyrrolidines, demonstrating the potential of peroxide-derived methyl radicals in constructing densely functionalised frameworks.

C–H Methylation Strategies in Medicinal Chemistry publication trend

The graph below shows the total number of articles in c–h methylation strategies in medicinal chemistry across all publications each year (not limited to Nature Index journals).

Technical terms

C(sp3)–H bond: A carbon–hydrogen bond on a saturated carbon atom, often requiring activation for functionalisation.

Late-stage functionalisation: Introduction of substituents into complex molecules at a late point in a synthetic sequence, avoiding de novo synthesis.

Directing group: A coordinating moiety that guides a metal catalyst to a specific C–H bond to achieve site-selective activation.

Regioselectivity: Preference for functionalisation at one position in a molecule over other possible sites.

Photochemical activation: Use of light energy to generate reactive species, such as radicals, under mild conditions.

Mechanochemistry: Chemical transformations induced by mechanical force, often under solvent-free grinding.

Magic methyl effect: The dramatic change in biological or physicochemical properties of a molecule upon incorporation of a methyl group.

References

1. Catalytic undirected methylation of unactivated C(sp3)−H bonds suitable for complex molecules. Nature Communications (2024).
2. Solvent-free and ball mill-free catalytic C–H methylation. Green Chemistry (2023).
3. Copper-catalyzed methylative difunctionalization of alkenes. Nature Communications (2018).
4. The Magic Methyl and Its Tricks in Drug Discovery and Development. Pharmaceuticals (2023).
5. C−H Methylation Using Sustainable Approaches. Catalysts (2022).